VESELY, O., P. MARSIK, V. JAROSOVA, I. DOSKOCIL, Karel ŠMEJKAL, P. KLOUCEK and J. HAVLIK. Metabolism of Selected 2-Arylbenzofurans in a Colon In Vitro Model System. Foods. BASEL: MDPI, 2021, vol. 10, No 11, p. 1-11. ISSN 2304-8158. Available from: https://dx.doi.org/10.3390/foods10112754.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Metabolism of Selected 2-Arylbenzofurans in a Colon In Vitro Model System
Authors VESELY, O., P. MARSIK (guarantor), V. JAROSOVA, I. DOSKOCIL, Karel ŠMEJKAL (203 Czech Republic, belonging to the institution), P. KLOUCEK and J. HAVLIK.
Edition Foods, BASEL, MDPI, 2021, 2304-8158.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30104 Pharmacology and pharmacy
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 5.561
RIV identification code RIV/00216224:14160/21:00124273
Organization unit Faculty of Pharmacy
Doi http://dx.doi.org/10.3390/foods10112754
UT WoS 000723342700001
Keywords in English moracin C; mulberrofuran G; mulberrofuran Y; permeability assay; Caco-2 cells; intestinal fermentation; LC-MS-Q-TOF
Tags rivok, ÚPL
Tags International impact, Reviewed
Changed by Changed by: JUDr. Sabina Krejčiříková, učo 383857. Changed: 23/2/2022 16:22.
Abstract
2-arylbenzofurans represent a small group of bioactive compounds found in the plant family Moraceae. As it has not been investigated whether these substances are stable during passage through the gastrointestinal tract, their biological effects may be altered by the metabolism of intestinal microbiota or cells. The aim of the present study was to investigate and compare mulberrofuran Y (1), moracin C (2), and mulberrofuran G (3) in an in vitro model of human intestinal bacterial fermentation and in an epithelial model using the Caco-2 cell line. The analysis of compounds by LC-MS-Q-TOF showed sufficient stability in the fermentation model, with no bacterial metabolites detected. However, great differences in the quantity of permeation were observed in the permeability assay. Moreover, mulberrofuran Y (1) and moracin C (2) were observed to be transformed into polar metabolites by conjugation. Among the test compounds, mulberrofuran Y (1) was mostly stable and accumulated in endothelial cells (85.3%) compared with mulberrofuran G (3) and moracin C (2) (14% and 8.2%, respectively). Thus, only a small amount of mulberrofuran Y (1) was conjugated. Moracin C (2) and mulberrofuran G (3) were metabolized almost completely, with only traces of the unchanged molecule being found on the apical and cellular sides of the system. Only conjugates of mulberrofuran Y (1) and moracin C (2) were able to reach the basolateral side. Our results provide the basic description of bioavailability of these three compounds, which is a necessary characteristic for final evaluation of bio-efficacy.
Links
MUNI/A/1688/2020, interní kód MUName: Izolace sekundárních metabolitů s potenciální biologickou aktivitou z rostlinných zdrojů (Acronym: Izolace sekundárních metabolitů)
Investor: Masaryk University
PrintDisplayed: 31/7/2024 03:19